BioNexus Gene Lab Corp Common stock (BGLC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BioNexus Gene Lab Corp Common stock, updated every trading day.
Health Care · Medical Specialities
Price
$1.06
−5.53% today
Market cap
$3M
Overall quality
50/100
Kronos AI 30-day
+37.7%
8 of 8 simulated paths end higher
BioNexus Gene Lab Corp Common stock (BGLC) is a Health Care company in Medical Specialities, worth $3M. It trades at $1.06, down 5.53% today. Its overall quality score is 50 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +37.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $1.56 (+37.7%) |
| Likely range | +33.9% … +41.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 24 |
| Solvency | 92 |
| Growth | 33 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medical Specialities
For information only, not investment advice. Prices updated: 2026-10-29.